Cargando…
MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes
BACKGROUND: The transcriptomic signature has not been fully elucidated in PV, as well as mRNA markers for clinical variables (thrombosis, leukemic transformation, survival, etc.). We attempted to reveal and validate crucial co-expression modules and marker mRNAs correlating with polycythemia vera (P...
Autores principales: | Guo, Chao, Gao, Ya-yue, Ju, Qian-qian, Wang, Min, Zhang, Chun-xia, Gong, Ming, Li, Zhen-ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166116/ https://www.ncbi.nlm.nih.gov/pubmed/34059095 http://dx.doi.org/10.1186/s12967-021-02913-3 |
Ejemplares similares
-
Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016) -
Thromboembolic events in polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2019) -
Genetic Background of Polycythemia Vera
por: Regimbeau, Mathilde, et al.
Publicado: (2022) -
Differential cytokine network profile in polycythemia vera and secondary polycythemia
por: Cacemiro, Maira da Costa, et al.
Publicado: (2020) -
Lemierre’s Syndrome in an Elderly Female Patient with Polycythemia Vera: Does Polycythemia Vera Predispose to Lemierre’s Syndrome?
por: Kundal, Sanchit V., et al.
Publicado: (2021)